ACS Publications. Most Trusted. Most Cited. Most Read
Discovery of SZJK-0421: A Novel Potent, Low Toxicity, Selective Second Generation of CRM1 Inhibitor for the Treatment of Both Hematological and Solid Tumors
My Activity

Figure 1Loading Img
    Article

    Discovery of SZJK-0421: A Novel Potent, Low Toxicity, Selective Second Generation of CRM1 Inhibitor for the Treatment of Both Hematological and Solid Tumors
    Click to copy article linkArticle link copied!

    • Hang Miao
      Hang Miao
      College of Life Science, Nanjing Normal University, No. 1 Wenyuan Road, Nanjing 210037, P. R. China
      More by Hang Miao
    • Yanru Qin
      Yanru Qin
      College of Life Science, Nanjing Normal University, No. 1 Wenyuan Road, Nanjing 210037, P. R. China
      More by Yanru Qin
    • DingLu Shao
      DingLu Shao
      College of Life Science, Nanjing Normal University, No. 1 Wenyuan Road, Nanjing 210037, P. R. China
      More by DingLu Shao
    • Qinghua Chen
      Qinghua Chen
      College of Life Science, Nanjing Normal University, No. 1 Wenyuan Road, Nanjing 210037, P. R. China
      More by Qinghua Chen
    • Yupeng Pan
      Yupeng Pan
      College of Life Science, Nanjing Normal University, No. 1 Wenyuan Road, Nanjing 210037, P. R. China
      More by Yupeng Pan
    • Meng Lei
      Meng Lei
      College of Science, Nanjing Forestry University, No. 159 Longpan Road, Nanjing 210037, P. R. China
      More by Meng Lei
    • Ruokun Wu
      Ruokun Wu
      College of Science, Nanjing Forestry University, No. 159 Longpan Road, Nanjing 210037, P. R. China
      More by Ruokun Wu
    • Xinran Ye
      Xinran Ye
      College of Science, Nanjing Forestry University, No. 159 Longpan Road, Nanjing 210037, P. R. China
      More by Xinran Ye
    • Xueyuan Wang*
      Xueyuan Wang
      College of Life Science, Nanjing Normal University, No. 1 Wenyuan Road, Nanjing 210037, P. R. China
      *Email: [email protected]
      More by Xueyuan Wang
    • Yongqiang Zhu*
      Yongqiang Zhu
      College of Life Science, Nanjing Normal University, No. 1 Wenyuan Road, Nanjing 210037, P. R. China
      *Email: [email protected]
    Other Access OptionsSupporting Information (4)

    Journal of Medicinal Chemistry

    Cite this: J. Med. Chem. 2024, 67, 22, 20595–20618
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acs.jmedchem.4c02169
    Published November 7, 2024
    Copyright © 2024 American Chemical Society

    Abstract

    Click to copy section linkSection link copied!
    Abstract Image

    Nuclear export factor chromosome region maintenance 1 (CRM1) mediated the transport of various growth-regulatory proteins and was frequently overexpressed in many hematologic and solid tumors. Selinexor (KPT-330) was the only approved CRM1 inhibitor, but the severe gastrointestinal and central nervous system toxicities limited its clinical application. In this manuscript, a series of novel second-generation CRM1 inhibitors were designed, in which SZJK-0421 was a more reversible inhibitor than KPT-330. The treatment of various tumor cells with SZJK-0421 significantly inhibited the function of CRM1. SZJK-0421 displayed good liver microsome stabilities and pharmacokinetic properties. Most importantly, SZJK-0421 reduced the direct damage to the gastrointestinal mucosa, and the brain plasma distribution ratio of SZJK-0421 was very low in Sprague-Dawley (SD) rats (3%), which avoided gastrointestinal reactions such as central nausea and vomiting caused by large permeability of blood–brain barrier. In addition, SZJK-0421 exhibited strong anticancer efficacy in xenograft models of both solid and hematological tumors.

    Copyright © 2024 American Chemical Society

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    Supporting Information

    Click to copy section linkSection link copied!

    The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c02169.

    • Nostandard abbreviations and acronyms (PDF)

    • Crystallographic data (PDB)

    • Synthetic route of compound Biotin-0421, NMR spectra of all target compounds, HPLC spectra of compound SZJK-0421, and the effect of compound SZJK-0421 on forelimb grip strength in SD rats (PDF)

    • Molecular formula strings (CSV)

    Terms & Conditions

    Electronic Supporting Information files are available without a subscription to ACS Web Editions. The American Chemical Society holds a copyright ownership interest in any copyrightable Supporting Information. Files available from the ACS website may be downloaded for personal use only. Users are not otherwise permitted to reproduce, republish, redistribute, or sell any Supporting Information from the ACS website, either in whole or in part, in either machine-readable form or any other form without permission from the American Chemical Society. For permission to reproduce, republish and redistribute this material, requesters must process their own requests via the RightsLink permission system. Information about how to use the RightsLink permission system can be found at http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    Click to copy section linkSection link copied!

    This article has not yet been cited by other publications.

    Journal of Medicinal Chemistry

    Cite this: J. Med. Chem. 2024, 67, 22, 20595–20618
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acs.jmedchem.4c02169
    Published November 7, 2024
    Copyright © 2024 American Chemical Society

    Article Views

    404

    Altmetric

    -

    Citations

    -
    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.